GSTP1 affects chemoresistance against camptothecin in human lung adenocarcinoma cells

Cancer Letters

Volumn 216, Issue 1, 2004, Pages 89-102

  Ishii, Takeo ^a   Teramoto, Shinji ^b   Matsuse, Takeshi ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Camptothecin; Glutathione; GSTP1; Lung adenocarcinoma cells; Necrosis

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BUTHIONINE SULFOXIMINE; CAMPTOTHECIN; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CARCINOMA, NON-SMALL-CELL LUNG; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; NECROSIS;

EID: 6944226722     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.05.018     Document Type: Article

References (36)

1. L.F. Liu, S.D. Desai, T.K. Li, Y. Mao, M. Sun, and S.P. Sim Mechanism of action of camptothecin Ann. NY Acad. Sci. 922 2000 1 10
2. M.L. Rothenberg CPT-11: an original spectrum of clinical activity Semin. Oncol. 23 1996 21 26
3. S.G. Spiro, and J.C. Porter State of the art. Lung cancer - Where are we today? Current advances in staging and nonsurgical treatment Am. J. Respir. Crit. Care Med. 166 2002 1166 1196
4. A. Saleem, T.K. Edwards, Z. Rasheed, and E.H. Rubin Mechanism of resistance to camptothecin Ann. NY Acad. Sci. 922 2000 46 55
5. B. Mannervik The isozymes of glutathione S-transferase Adv. Enzymol. 57 1985 357 417
6. T.C. Shea, S.L. Kelley, and W.D. Henner Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines Cancer Res 48 1988 527 533
7. V. Adler, Z. Yin, S.Y. Fuchs, M. Benezra, L. Rosario, and K.D. Tew Regulation of JNK signaling by GSTp Eur. Mol. Biol. Org. J. 18 1999 1321 1334
8. N. Ban, Y. Takahashi, T. Takayama, T. Kura, T. Katahira, S. Sakamaki, and Y. Niitsu Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide Cancer Res. 56 1996 3577 3582
9. M. O'Brien, G.D. Kruh, and K.D. Tew The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance J. Pharmacol. Exp. Ther. 294 2000 480 487
10. Y. Saburi, M. Nakagawa, M. Ono, M. Sakai, M. Muramatsu, K. Kohno, and M. Kuwano Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of a Chinese hamster ovary cell line Cancer Res. 49 1989 7020 7025
11. J.A. Moscow, C.R. Fairchild, M.J. Madden, D.T. Ransom, H.S. Wieand, and E.E. O'Brien Expression of anionic glutathione-S-transferase and p-glycoprotein genes in human tissues and tumors Cancer Res. 49 1989 1422 1428
12. T. Arai, Y. Yasuda, T. Takaya, K. Hayakawa, S. Toshima, and C. Shibuya Immunohistochemical expression of glutathione transferase-pi in untreated primary non-small-cell lung cancer Cancer Detect. Prev. 24 2000 252 257
13. Y. Nakanishi, M. Kawasaki, F. Bai, K. Takayama, X.H. Pei, and K. Takano Expression of p53 and glutathione S-transferase-pi relates to clinical drug resistance in non-small cell lung cancer Oncology 57 1999 318 323
14. T. Hida, M. Kuwabara, Y. Ariyoshi, T. Takahashi, T. Sugiura, and K. Hosoda Serum glutathione S-transferase-pi level as a tumor marker for non-small cell lung cancer. Potential predictive value in chemotherapeutic response Cancer 73 1994 1377 1382
15. T. Oguri, Y. Fujiwara, O. Katoh, H. Daga, N. Ishikawa, and K. Fujitaka Glutathione S-transferase-pi gene expression and platinum drug exposure in human lung cancer Cancer Lett. 156 2000 93 99
16. T. Hara, T. Ishii, M. Fujishiro, M. Masuda, T. Ito, and J. Nakajima Glutathione S-transferase P1 has protective effects on cell viability against camptothecin Cancer Lett. 103 2004 199 207
17. T. Ishii, T. Matsuse, S. Teramoto, H. Matsui, M. Miyao, and T. Hosoi Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease Thorax 54 1999 693 696
18. A. Nakashio, N. Fujita, S. Rokudai, S. Sato, and T. Tsuruo Prevention of phosphatidylinositol 3′-kinase-akt survival signaling pathway during topotecan-induced apoptosis Cancer Res. 60 2000 5303 5309
19. L. Scott, J. Lamb, S. Smith, and D.N. Wheatley Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells Br. J. Cancer 83 2000 800 810
20. S. Goto, Y. Ihara, Y. Urata, S. Izumi, K. Abe, and T. Kondo Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase pi Fed. Am. Soc. Exp. Biol. J. 15 2001 2702 2714
21. N. Watanabe, T. Iwamoto, D.A. Dickinson, K.E. Iles, and H.J. Forman Activation of the mitochondrial caspase cascade in the absence of protein synthesis does not require c-Jun N-terminal kinase Arch. Biochem. Biophys. 405 2002 231 240
22. A.S. Johansson, G. Stenberg, M. Widersten, and B. Mannervik Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105 J. Mol. Biol. 278 1998 687 698
23. T. Ishii, M. Fujishiro, M. Masuda, J. Nakajima, S. Teramoto, Y. Ouchi, and T. Matsuse Depletion of glutathione S-transferase P1 induces apoptosis in human lung fibroblasts Exp. Lung Res. 29 2003 523 536
24. E. Uchida, H. Mizuguchi, A. Ishii-Watanabe, and T. Hayakawa Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cells Biol. Pharm. Bull. 25 2002 891 897
25. E. Gupta, F. Luo, A. Lallo, S. Ramanathan, V. Vyas, E. Rubin, and P. Sinko The intestinal absorption of camptothecin, a highly lipophilic drug, across Caco-2 cells is mediated by active transporter(s) Anticancer Res. 20 2000 1013 1016
26. A.Y. Chen, C. Yu, M. Potmesil, M.E. Wal, M.C. Wani, and L.F. Lif Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells Cancer Res. 51 1991 6039 6044
27. N.S. Chang Hyaluronidase activation of c-Jun N-terminal kinase is necessary for protection of L929 fibrosarcoma cells from staurosporine-mediated cell death Biochem. Biophys. Res. Commun. 283 2001 278 286
28. 2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis J. Biol. Chem. 272 1997 4631 4636
29. A. Ishisaki, H. Hayashi, S. Suzuki, K. Ozawa, E. Mizukoshi, and K. Miyakawa Glutathione S-transferase Pi is a dopamine-inducible suppressor of dopamine-induced apoptosis in PC12 cells J. Neurochem. 77 2001 1362 1371
30. M.P. Gamcsik, M.S. Kasibhatla, D.J. Adams, J.L. Flowers, O.M. Colvin, and G. Manikumar Dual role of glutathione in modulating camptothecin activity: depletion potentiates activity, but conjugation enhances the stability of the topoisomerase I-DNA cleavage complex Mol. Cancer Ther. 1 2001 11 20
31. A. Troyano, C. Fernandez, P. Sancho, E. de Blas, and P. Aller Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells. The role of intracellular oxidation J. Biol. Chem. 276 2001 47107 47115
32. B. Ketterer Glutathione S-transferases and prevention of cellular free radical damage Free Rad. Res. 28 1998 647 658
33. U. Pandya, S.K. Srivastava, S.S. Singhal, A. Pal, S. Awasthi, and P. Zimniak Activity of allelic vatiants of Pi class human glutathione S-transferase toward chlorambucil Biochem. Biophys. Res. Commun. 278 2000 258 262
34. P. Yang, A. Yokomizo, H.D. Tazelaar, R.S. Marks, T.G. Lesnick, and D.L. Miller Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes Lung Cancer 35 2002 221 229
35. S. Lee, H.S. Lee, M. Baek, D.Y. Lee, Y.J. Bang, and H.N. Cho MAPK signaling is involved in camptothecin-induced cell death Mol. Cells 14 2002 248 254
36. A. Nakashio, N. Fujita, S. Rokudai, S. Sato, and T. Tsuruo Prevention of phosphatidylinositol 3′-kinase Akt survival signaling pathways during topotecan-induced apoptosis Cancer Res. 60 2000 5303 5309